Effectiveness of Percutaneous Foraminotomy

November 3, 2015 updated by: Sangchul Lee, Seoul National University Hospital

Effectiveness of Percutaneous Foraminotomy in Patients With Lumbar Foraminal Stenosis: A Prospective, Pilot Study

Percutaneous Extraforaminotomy using BS extraforamonotomy kit(BioSpine Co.,Ltd, Seoul, South Korea), was performed in patients who did not show improvement lasting more than 1 month after diagnostic conventional fluoroscopically guided transforaminal epidural block with local anesthetic and steroid.

Numeric rating scale(NRS) pain score, Oswestry disability index (ODI), Roland-Morris Disability Questionnaire (RDQ), claudication distance(CD) was checked before and after the procedure.

Study Overview

Status

Unknown

Conditions

Detailed Description

Percutaneous Extraforaminotomy with Transforaminal Adhesiolysis may be an effective minimal invasive technique in patients not responsive to conventional epidural steroid injection.

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Seoul, Korea, Republic of, 110-744
        • Recruiting
        • Seoul National University Hospital
        • Contact:
        • Sub-Investigator:
          • JeeYoun Moon, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 85 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • radicular pain with positive provocation factors > 3 months
  • Radicular pain at L4 or L5
  • Presence of dominant side when bilateral symptom present
  • Positive provocation factors: leg symptoms elicited or aggravated by walking but relieved by sitting down
  • Not appropriate relief of pain routinely conservative treatment (physiotherapy, exercise, analgesic medication, epidural steroid injection) > 3 months
  • Magnetic resonance imaging(MRI) : Foraminal stenosis of Grade 1-3 (foraminal herniated intervertebral disc(HIVD) with mild to severe degree of foraminal stenosis according to AJR:194, April 2010 by Lee, et. Al)
  • Subjects who signed for the consent form

Exclusion Criteria:

  1. Acute back or leg pain
  2. Sings of progressive neurologic deficits, including muscle atrophy and abnormal tendon reflexes
  3. Patients with a history of prior spine surgery
  4. Allergic response to steroid or contrast dye
  5. Bleeding diathesis or over coagulopathy
  6. Patients with bilateral radiculopathy or spinal stenosis at more than 3 levels

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Treatment group
Percutaneous Extraforaminotomy using BS extraforamonotomy kit(BioSpine Co.,Ltd, Seoul, South Korea)
percutaneous dissecting of the lumbar extraforaminal and foraminal region with BS extraforamonotomy kit(BioSpine Co.,Ltd, Seoul, South Korea) under fluoroscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NRS score
Time Frame: 4 weeks after intervention
A comparison of the mean difference in the change of NRS scores of their leg pain from entry to the scores at 4-week
4 weeks after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NRS score
Time Frame: 8, 12 weeks after intervention
A comparison of the mean difference in the change of NRS scores of their leg pain from entry to the scores at 8, 12-weeks after intervention
8, 12 weeks after intervention
Oswestry disability index(ODI)
Time Frame: 4, 8 and 12 weeks after intervention
A change of ODI over periods of time after intervention (12 weeks)
4, 8 and 12 weeks after intervention
5-point satisfaction scale
Time Frame: 4, 8 and 12 weeks
Patient satisfaction with treatment at 4, 8, & 12 weeks
4, 8 and 12 weeks
Any adverse events
Time Frame: Throughout the study period (up to 12 weeks)
Throughout the study period (up to 12 weeks)
Roland-Morris Disability Questionnaire(RDQ)
Time Frame: 4, 8 and 12 weeks after intervention
A change of RDQ change over periods of time after intervention (12 weeks)
4, 8 and 12 weeks after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Sangchul Lee, MD, PhD, Seoul National University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (ANTICIPATED)

January 1, 2016

Study Completion (ANTICIPATED)

January 1, 2016

Study Registration Dates

First Submitted

October 6, 2015

First Submitted That Met QC Criteria

November 3, 2015

First Posted (ESTIMATE)

November 5, 2015

Study Record Updates

Last Update Posted (ESTIMATE)

November 5, 2015

Last Update Submitted That Met QC Criteria

November 3, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Stenosis

Clinical Trials on Percutaneous Extraforaminotomy

3
Subscribe